ACADIA Pharmaceuticals Inc. vs Vistra Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.42 (market cap $5.07B), while Vistra Corp trades at $145.76 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 9.6× ACADIA Pharmaceuticals Inc.'s market cap, and Vistra Corp pays a 0.63% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | VST | |
|---|---|---|
Market Cap | $5.07B | $48.64B |
Sector | Health | Technology |
52-Week High | $29.41 | $217.92 |
52-Week Low | $20.06 | $134.71 |
Enterprise Value | $4.19B | $70.58B |
Dividend Yield | — | 0.63% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →